The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksEntain Regulatory News (ENT)

Share Price Information for Entain (ENT)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 818.20
Bid: 817.40
Ask: 818.80
Change: 34.00 (4.34%)
Spread: 1.40 (0.171%)
Open: 783.80
High: 819.80
Low: 772.60
Prev. Close: 784.20
ENT Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

TR1: Notification of Major Holdings

16 Apr 2024 09:17

RNS Number : 7991K
Entain PLC
16 April 2024
 

TR-1: Standard form for notification of major holdings

1. Issuer Details

ISIN

IM00B5VQMV65

Issuer Name

ENTAIN PLC

UK or Non-UK Issuer

Non-UK

2. Reason for Notification

An acquisition or disposal of voting rights

3. Details of person subject to the notification obligation

Name

The Capital Group Companies, Inc.

City of registered office (if applicable)

Los Angeles

Country of registered office (if applicable)

USA

4. Details of the shareholder

Full name of shareholder(s) if different from the person(s) subject to the notification obligation, above

 

City of registered office (if applicable)

 

Country of registered office (if applicable)

 

5. Date on which the threshold was crossed or reached

12-Apr-2024

6. Date on which Issuer notified

15-Apr-2024

7. Total positions of person(s) subject to the notification obligation

% of voting rights attached to shares (total of 8.A)

% of voting rights through financial instruments (total of 8.B 1 + 8.B 2)

Total of both in % (8.A + 8.B)

Total number of voting rights held in issuer

Resulting situation on the date on which threshold was crossed or reached

15.160000

0.000000

15.160000

96843596

Position of previous notification (if applicable)

14.810000

0.000000

14.810000

8. Notified details of the resulting situation on the date on which the threshold was crossed or reached

8A. Voting rights attached to shares

Class/Type of shares ISIN code(if possible)

Number of direct voting rights (DTR5.1)

Number of indirect voting rights (DTR5.2.1)

% of direct voting rights (DTR5.1)

% of indirect voting rights (DTR5.2.1)

IM00B5VQMV65 Common Stock

0

96843522

0.000000

15.160000

US2936031069 Depository Receipt

0

74

0.000000

0.000000

Sub Total 8.A

96843596

15.160000%

8B1. Financial Instruments according to (DTR5.3.1R.(1) (a))

Type of financial instrument

Expiration date

Exercise/conversion period

Number of voting rights that may be acquired if the instrument is exercised/converted

% of voting rights

 

Sub Total 8.B1

8B2. Financial Instruments with similar economic effect according to (DTR5.3.1R.(1) (b))

Type of financial instrument

Expiration date

Exercise/conversion period

Physical or cash settlement

Number of voting rights

% of voting rights

 

Sub Total 8.B2

9. Information in relation to the person subject to the notification obligation

2. Full chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held starting with the ultimate controlling natural person or legal entities (please add additional rows as necessary)

Ultimate controlling person

Name of controlled undertaking

% of voting rights if it equals or is higher than the notifiable threshold

% of voting rights through financial instruments if it equals or is higher than the notifiable threshold

Total of both if it equals or is higher than the notifiable threshold

The Capital Group Companies, Inc.

Capital Research and Management Company

14.830000

0.000000

14.830000%

The Capital Group Companies, Inc.

Capital International, Inc.

The Capital Group Companies, Inc.

Capital International Sarl

The Capital Group Companies, Inc.

Capital Group Private Client Services, Inc.

The Capital Group Companies, Inc.

EuroPacific Growth Fund (a mutual fund managed by Capital Research and Management Company)

5.060000

0.000000

5.060000%

10. In case of proxy voting

Name of the proxy holder

 

The number and % of voting rights held

 

The date until which the voting rights will be held

 

11. Additional Information

The Capital Group Companies, Inc. ("CGC") is the parent company of Capital Research and Management Company ("CRMC") and Capital Bank & Trust Company ("CB&T"). CRMC is a U.S.-based investment management company that serves as investment manager to the American Funds family of mutual funds, other pooled investment vehicles, as well as individual and institutional clients. CRMC and its investment manager affiliates manage equity assets for various investment companies through three divisions, Capital Research Global Investors, Capital International Investors and Capital World Investors. CRMC is the parent company of Capital Group International, Inc. ("CGII"), which in turn is the parent company of six investment management companies ("CGII management companies"): Capital International, Inc., Capital International Limited, Capital International Sàrl, Capital International K.K., Capital Group Private Client Services Inc, and Capital Group Investment Management Private Limited. CGII management companies primarily serve as investment managers to institutional and high net worth clients. CB&T is a U.S.-based registered investment adviser and an affiliated federally chartered bank.Neither CGC nor any of its affiliates own shares of the Issuer for its own account. Rather, the shares reported on this Notification are owned by accounts under the discretionary investment management of one or more of the investment management companies described above.

12. Date of Completion

15-Apr-2024

13. Place Of Completion

Los Angeles

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
HOLVQLBFZZLFBBZ
Date   Source Headline
29th Apr 20247:00 amRNSSuccessful repricing of Term Loans & £600m add-on
26th Apr 20249:56 amRNSBoard Committee Changes
24th Apr 202412:09 pmRNSResult of AGM
17th Apr 20247:00 amRNSQ1 Trading Update
16th Apr 20249:17 amRNSTR1: Notification of Major Holdings
4th Apr 20247:00 amRNSChairman Succession
2nd Apr 20247:00 amRNSBlock Listing Six Monthly Return
2nd Apr 20247:00 amRNSTotal Voting Rights
22nd Mar 20247:42 amRNSAnnual Report, AGM and Gender Pay Gap Report
12th Mar 202411:41 amRNSDirector/PDMR Shareholding
12th Mar 202410:00 amRNSBoard Appointment
11th Mar 20241:54 pmRNSDirector/PDMR Shareholding
7th Mar 20247:00 amRNSFY23 results in line with expectations
1st Mar 20247:00 amRNSTotal Voting Rights
19th Feb 20247:00 amRNSTR1: Notification of Major Holdings
8th Feb 20242:00 pmRNSBETMGM FY23 UPDATE
6th Feb 20242:00 pmRNSNotice of BetMGM FY 2023 update
2nd Feb 20244:11 pmRNSNew Board Committee
1st Feb 20247:00 amRNSTotal Voting Rights
3rd Jan 20249:27 amRNSTR1: Notification of Major Holdings
3rd Jan 20247:00 amRNSBoard Appointment
2nd Jan 20248:29 amRNSTotal Voting Rights
15th Dec 20234:00 pmRNSBoard Committee Changes
13th Dec 20237:00 amRNSDirectorate Change
6th Dec 202310:00 amRNSDirector/PDMR Shareholding
6th Dec 20237:00 amRNSBetMGM at Morgan Stanley Consumer Conference
5th Dec 20232:06 pmRNSFinal Approval of Deferred Prosecution Agreement
4th Dec 20232:00 pmRNSBetMGM Business Update
1st Dec 20237:00 amRNSTotal Voting Rights
30th Nov 202310:42 amRNSStatement regarding KSA decisions
27th Nov 20232:00 pmRNSBetMGM Business Update Event Details
24th Nov 20232:01 pmRNSUpdate on Deferred Prosecution Agreement
15th Nov 202311:00 amRNSDirector/PDMR Shareholding
8th Nov 20232:00 pmRNSTR1: Notification of Major Holdings
8th Nov 20237:00 amRNSDirector/PDMR Shareholding
7th Nov 20233:39 pmRNSTR1: Notification of Major Holdings
6th Nov 20239:12 amRNSTR1: Notification of Major Holdings
2nd Nov 20237:00 amRNSQ3 Trading Statement & Business Update
1st Nov 20237:00 amRNSTotal Voting Rights
31st Oct 20237:00 amRNSBoard Appointment
4th Oct 20232:00 pmRNSNotice of BETMGM Business Update Event
4th Oct 202311:30 amRNSTR1: Notification of Major Holdings
2nd Oct 202312:35 pmRNSBlock Listing Six Monthly Return
2nd Oct 20239:11 amRNSTotal Voting Rights
2nd Oct 20237:00 amRNSCompletion of acquisition of Angstrom Sports
25th Sep 20237:00 amRNSUpdate on current trading and operational strategy
5th Sep 20232:00 pmRNSBetMGM participate in Bank of America Conference
1st Sep 202310:02 amRNSTotal Voting Rights
21st Aug 20235:15 pmRNSResult of tender offer to shareholders of STS
10th Aug 20237:01 amRNSUpdate on HMRC Investigation

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.